In-depth analysis of the English name of Gefapixant Citrate

The English name of Gefapixant Citrate is Gefapixant Citrate, and its naming system is closely related to the drug’s molecular structure and mechanism of action. In pharmaceutical nomenclature, the "Gefa-" part of Gefapixant is usually used to represent a medicinal chemistry series or core skeleton, "-pixant" is related to its receptor targeting properties, pointing to its inhibitory or modulatory effect on a specific receptor, and "Citrate" indicates that the compound is in the citrate form. The presence of the drug in citrate form helps improve its water solubility, stability and oral absorption, which is particularly important for clinical applications.

The English naming of Gefapixant not only follows the International Nonproprietary Name (INN) system, but also reflects its pharmacological characteristics and drug development strategy. It is a P2X3 receptor antagonist. Its core function is to regulate the excitability of cough reflex nerves in patients with chronic cough by selectively inhibiting the activity of P2X3 receptors, thereby reducing cough frequency and improving patients' quality of life. The English name "Gefapixant Citrate" is used uniformly in scientific research documents, drug instructions and clinical trials, which facilitates the docking of transnational pharmaceutical research and market supervision.

From the perspective of drug development,The naming of Gefapixant also reflects the pharmaceutical company's strategy for the international market: the English name clearly conveys the drug's targeting effect and chemical salt form, which helps clinicians and patients understand its characteristics and is also easy to distinguish from generic drugs and other R&D drugs. The citrate form is widely used in pharmaceutical formulations to improve the stability of oral medications while reducing gastrointestinal irritation and improving patient compliance. This makes Gefapixant not only unique in scientific research naming, but also has medicinal chemistry optimization advantages in practical applications.

In short,The design of the English name Gefapixant Citrate not only reflects the chemical structure of the drug, but also reflects its clinical targeting properties and salt form advantages. It provides a scientific and accurate pharmaceutical label for the treatment of chronic cough, and at the same time facilitates global market circulation, scientific research exchanges and clinical applications.

Reference materials:https://synapse.patsnap.com